Stockreport

How Strong Galafold and Pombiliti Sales Helped Amicus Therapeutics (FOLD) Surpass Expectations and Shift Its Outlook [Yahoo! Finance]

Amicus Therapeutics, Inc.  (FOLD) 
Last amicus therapeutics, inc. earnings: 11/11 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.amicusrx.com/investor-relations
PDF Amicus Therapeutics reported third-quarter 2025 earnings that surpassed analyst expectations, posting an EPS of US$0.06 and revenue of US$169.1 million driven by strong [Read more]